Literature DB >> 21219180

SLAM family receptors and SAP adaptors in immunity.

Jennifer L Cannons1, Stuart G Tangye, Pamela L Schwartzberg.   

Abstract

The signaling lymphocyte activation molecule (SLAM)-associated protein, SAP, was first identified as the protein affected in most cases of X-linked lymphoproliferative (XLP) syndrome, a rare genetic disorder characterized by abnormal responses to Epstein-Barr virus infection, lymphoproliferative syndromes, and dysgammaglobulinemia. SAP consists almost entirely of a single SH2 protein domain that interacts with the cytoplasmic tail of SLAM and related receptors, including 2B4, Ly108, CD84, Ly9, and potentially CRACC. SLAM family members are now recognized as important immunomodulatory receptors with roles in cytotoxicity, humoral immunity, autoimmunity, cell survival, lymphocyte development, and cell adhesion. In this review, we cover recent findings on the roles of SLAM family receptors and the SAP family of adaptors, with a focus on their regulation of the pathways involved in the pathogenesis of XLP and other immune disorders.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21219180     DOI: 10.1146/annurev-immunol-030409-101302

Source DB:  PubMed          Journal:  Annu Rev Immunol        ISSN: 0732-0582            Impact factor:   28.527


  208 in total

1.  ICOS receptor instructs T follicular helper cell versus effector cell differentiation via induction of the transcriptional repressor Bcl6.

Authors:  Youn Soo Choi; Robin Kageyama; Danelle Eto; Tania C Escobar; Robert J Johnston; Laurel Monticelli; Christopher Lao; Shane Crotty
Journal:  Immunity       Date:  2011-06-24       Impact factor: 31.745

Review 2.  Cell surface signaling molecules in the control of immune responses: a tide model.

Authors:  Yuwen Zhu; Sheng Yao; Lieping Chen
Journal:  Immunity       Date:  2011-04-22       Impact factor: 31.745

3.  Positive and negative signaling through SLAM receptors regulate synapse organization and thresholds of cytolysis.

Authors:  Fang Zhao; Jennifer L Cannons; Mala Dutta; Gillian M Griffiths; Pamela L Schwartzberg
Journal:  Immunity       Date:  2012-06-07       Impact factor: 31.745

Review 4.  Infectious Mononucleosis.

Authors:  Samantha K Dunmire; Kristin A Hogquist; Henry H Balfour
Journal:  Curr Top Microbiol Immunol       Date:  2015       Impact factor: 4.291

5.  Signaling Lymphocytic Activation Molecule Family Receptor Homologs in New World Monkey Cytomegaloviruses.

Authors:  Natàlia Pérez-Carmona; Domènec Farré; Pablo Martínez-Vicente; Cox Terhorst; Pablo Engel; Ana Angulo
Journal:  J Virol       Date:  2015-09-02       Impact factor: 5.103

6.  Elotuzumab in combination with lenalidomide and dexamethasone in patients with relapsed multiple myeloma: final phase 2 results from the randomised, open-label, phase 1b-2 dose-escalation study.

Authors:  Paul G Richardson; Sundar Jagannath; Philippe Moreau; Andrzej J Jakubowiak; Marc S Raab; Thierry Facon; Ravi Vij; Darrell White; Donna E Reece; Lotfi Benboubker; Jeffrey Zonder; L Claire Tsao; Kenneth C Anderson; Eric Bleickardt; Anil K Singhal; Sagar Lonial
Journal:  Lancet Haematol       Date:  2015-11-16       Impact factor: 18.959

7.  A hematopoietic cell-driven mechanism involving SLAMF6 receptor, SAP adaptors and SHP-1 phosphatase regulates NK cell education.

Authors:  Ning Wu; Ming-Chao Zhong; Romain Roncagalli; Luis-Alberto Pérez-Quintero; Huaijian Guo; Zhanguang Zhang; Christelle Lenoir; Zhongjun Dong; Sylvain Latour; André Veillette
Journal:  Nat Immunol       Date:  2016-02-15       Impact factor: 25.606

8.  Fine-tuning of CD8(+) T-cell effector functions by targeting the 2B4-CD48 interaction.

Authors:  Anna Lissina; David R Ambrozak; Kristin L Boswell; Wenjing Yang; Eli Boritz; Yoshiyuki Wakabayashi; Maria C Iglesias; Masao Hashimoto; Masafumi Takiguchi; Elias Haddad; Daniel C Douek; Jun Zhu; Richard A Koup; Takuya Yamamoto; Victor Appay
Journal:  Immunol Cell Biol       Date:  2016-02-10       Impact factor: 5.126

Review 9.  Novel anti-myeloma immunotherapies targeting the SLAM family of receptors.

Authors:  Sabarinath Venniyil Radhakrishnan; Neelam Bhardwaj; Tim Luetkens; Djordje Atanackovic
Journal:  Oncoimmunology       Date:  2017-03-28       Impact factor: 8.110

Review 10.  Role of diacylglycerol kinases in T cell development and function.

Authors:  Sruti Krishna; Xiaoping Zhong
Journal:  Crit Rev Immunol       Date:  2013       Impact factor: 2.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.